Search | IOVS | ARVO Journals

Showing 1 – 20 of 36

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Glaucoma October 2017

Intraday Repeatability of Bruch's Membrane Opening-Based Neuroretinal Rim Measurements

PDF

Philip Enders; Andreas Bremen; Friederike Schaub; Manuel M. Hermann; Michael Diestelhorst; Thomas Dietlein; Claus Cursiefen; Ludwig M. Heindl
TAGS: magnetic resonance angiography, glaucoma, bruch's basal membrane, optic disk, retinal nerve fiber layer, mineralocorticoid receptor antagonists, neuroretinal rim, spectral-domain optical coherence tomography
Invest. Ophthalmol. Vis. Sci.. 2017; 58(12):5195-5200. doi: https://doi.org/10.1167/iovs.17-22812

ARVO Annual Meeting Abstract March 2012

The Effect Of General Anesthesia On Rebound Tonometry Measurements In Normal Eyes Of Preschool Children

Andrea M. Schild; Manuel M. Hermann; Julia Fricke; Antje Neugebauer; Michael Diestelhorst

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):6778. doi:

ARVO Annual Meeting Abstract March 2012

Effect of a new Audible and Visual Reminder Device on Adherence with Topical Latanoprost for Glaucoma

Manuel M. Hermann; Alain M. Bron; Catherine P. Creuzot-Garcher; Michael Diestelhorst

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):5108. doi:

ARVO Annual Meeting Abstract April 2011

Effect of a new Audible and Visual Reminder Device on Adherence with Topical Timolol for Glaucoma

Manuel M. Hermann; Lebriz Ersoy; Michael Diestelhorst

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):212. doi:

ARVO Annual Meeting Abstract April 2011

Correlation Of Iop And Individual Adherence With The Fixed Travoprost / Timolol Therapy. A Multi-centre Study In Ambulant Glaucoma Patients

Michael Diestelhorst; Travalert Study Group

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):230. doi:

ARVO Annual Meeting Abstract April 2010

Comparison of Rapamycin and Mitomycin for Reduction of Postoperative Fibrosis After Filtration Surgery in a Rabbit Model

M. M. Hermann; B. Schröter; M. Diestelhorst

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):3199. doi:

ARVO Annual Meeting Abstract April 2010

The Ocular Bioavailability of Latanoprost Lyophilizate 0.75 µg Compared With Xalatan® 1.5 µg

M. Diestelhorst; S. Fauser; K. Gruner; R. Sueverkruep

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):5307. doi:

ARVO Annual Meeting Abstract April 2010

Laser Flare-Cell Meter Being a Prognostic Non-Invasive Tool for Detecting Proliferative Vitreoretinopathy (PVR)

S. Schroeder; A. Caramoy; P. S. Muether; M. Diestelhorst; B. Kirchhof; S. Fauser

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):6080. doi:

ARVO Annual Meeting Abstract April 2010

A New Reminder System Improves Adherence With Topical Ocular Therapy Significantly

L. Ersoy; M. M. Hermann; M. Diestelhorst

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):181. doi:

ARVO Annual Meeting Abstract April 2009

Quantification of Changes in the Ocular Barrier Function in Eyes With Retinal Detachment by Laser Flare Cell Meter

S. Schroeder; A. Caramoy; P. Muether; M. Abdel-Salam; M. Diestelhorst; B. Kirchhof; S. Fauser

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):3162. doi:

ARVO Annual Meeting Abstract April 2009

Effect of Rapamycin on Postoperative Fibrosis After Filtration Surgery in a Rabbit Model

M. M. Hermann; B. Schröter; M. Diestelhorst

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):3910. doi:

ARVO Annual Meeting Abstract April 2009

Latanoprost Ophthalmic Lyophilizate Carrier Systems (OLCS)

K. Gruner; R. Suverkrup; M. Diestelhorst

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):5555. doi:

ARVO Annual Meeting Abstract April 2009

Spherolyophilizates as Ophthalmic Drug Delivery Systems

R. Suverkrup; K. Gruner; M. Diestelhorst

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):5557. doi:

ARVO Annual Meeting Abstract May 2008

Electronic Compliance Monitoring in Glaucoma Patients Used to Topical Therapy

M. M. Hermann; A. M. Bron; C. P. Creuzot-Garcher; M. Diestelhorst

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):1582. doi:

ARVO Annual Meeting Abstract May 2008

Optic Nerve Head Characteristics Using Cofocal Laser Scanning Tomography in Glaucoma Patients

M. Diestelhorst; P. Enders; M. M. Hermann

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):3644. doi:

ARVO Annual Meeting Abstract May 2007

Compliance With Brimonidine Therapy in Patients Aware of Individual Electronic Compliance Monitoring

M. M. Hermann; D. Papaconstantinou; G. Georgopoulos; M. Diestelhorst

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):5576. doi:

ARVO Annual Meeting Abstract May 2007

Monitoring Individual Compliance in Glaucoma Patients Used to Topical Therapy

A. M. Bron; M. M. Hermann, Jr.; C. Creuzot-Garcher; M. Diestelhorst

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):5580. doi:

ARVO Annual Meeting Abstract May 2007

Comparative Ocular Pharmacokinetics of Fluorescein Following Application as Lyophilisate and Conventional Eye Drops

M. Diestelhorst; o. Doroshyenko; A. Lux; K. Abduljalil; A. Steinfeld; S. Dinslage; R. Sueverkruep; U. Fuhr

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):5793. doi:

ARVO Annual Meeting Abstract May 2006

Fast Precise Freeze Drying of Hyaluronic Acid / Dextran Ophthalmic Lyophilisate Carrier Systems (OLCS)

R.J. Suverkrup; O. Krasichkova; M. Diestelhorst

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):5130. doi:

ARVO Annual Meeting Abstract May 2006

Monitoring Individual Adherence With Topical Therapy After Glaucoma Surgery

C. Ustundag; M.M. Hermann; M. Diestelhorst

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):5493. doi:

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Intraday Repeatability of Bruch's Membrane Opening-Based Neuroretinal Rim Measurements

The Effect Of General Anesthesia On Rebound Tonometry Measurements In Normal Eyes Of Preschool Children

Effect of a new Audible and Visual Reminder Device on Adherence with Topical Latanoprost for Glaucoma

Effect of a new Audible and Visual Reminder Device on Adherence with Topical Timolol for Glaucoma

Correlation Of Iop And Individual Adherence With The Fixed Travoprost / Timolol Therapy. A Multi-centre Study In Ambulant Glaucoma Patients

Comparison of Rapamycin and Mitomycin for Reduction of Postoperative Fibrosis After Filtration Surgery in a Rabbit Model

The Ocular Bioavailability of Latanoprost Lyophilizate 0.75 µg Compared With Xalatan® 1.5 µg

Laser Flare-Cell Meter Being a Prognostic Non-Invasive Tool for Detecting Proliferative Vitreoretinopathy (PVR)

A New Reminder System Improves Adherence With Topical Ocular Therapy Significantly

Quantification of Changes in the Ocular Barrier Function in Eyes With Retinal Detachment by Laser Flare Cell Meter

Effect of Rapamycin on Postoperative Fibrosis After Filtration Surgery in a Rabbit Model

Latanoprost Ophthalmic Lyophilizate Carrier Systems (OLCS)

Spherolyophilizates as Ophthalmic Drug Delivery Systems

Electronic Compliance Monitoring in Glaucoma Patients Used to Topical Therapy

Optic Nerve Head Characteristics Using Cofocal Laser Scanning Tomography in Glaucoma Patients

Compliance With Brimonidine Therapy in Patients Aware of Individual Electronic Compliance Monitoring

Monitoring Individual Compliance in Glaucoma Patients Used to Topical Therapy

Comparative Ocular Pharmacokinetics of Fluorescein Following Application as Lyophilisate and Conventional Eye Drops

Fast Precise Freeze Drying of Hyaluronic Acid / Dextran Ophthalmic Lyophilisate Carrier Systems (OLCS)

Monitoring Individual Adherence With Topical Therapy After Glaucoma Surgery

To View More...

You must be signed into an individual account to use this feature.